Literature DB >> 22155372

A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents.

Tetsuhisa Hattori1, Takeru Makiyama, Masaharu Akao, Eiji Ehara, Seiko Ohno, Moritake Iguchi, Yukiko Nishio, Kenichi Sasaki, Hideki Itoh, Masayuki Yokode, Toru Kita, Minoru Horie, Takeshi Kimura.   

Abstract

AIMS: Short-QT syndrome (SQTS) is a recently recognized disorder associated with atrial fibrillation (AF) and sudden death due to ventricular arrhythmias. Mutations in several ion channel genes have been linked to SQTS; however, the mechanism remains unclear. This study describes a novel heterozygous gain-of-function mutation in the inward rectifier potassium channel gene, KCNJ2, identified in SQTS. METHODS AND
RESULTS: We studied an 8-year-old girl with a markedly short-QT interval (QT = 172 ms, QTc = 194 ms) who suffered from paroxysmal AF. Mutational analysis identified a novel heterozygous KCNJ2 mutation, M301K. Functional assays displayed no Kir2.1 currents when M301K channels were expressed alone. However, co-expression of wild-type (WT) with M301K resulted in larger outward currents than the WT at more than -30 mV. These results suggest a gain-of-function type modulation due to decreased inward rectification. Furthermore, we analysed the functional significance of the amino acid charge at M301 (neutral) by changing the residue. As with M301K, in M301R (positive), the homozygous channels were non-functional, whereas the heterozygous channels demonstrated decreased inward rectification. Meanwhile, the currents recorded in M301A (neutral) showed normal inward rectification under both homo- and heterozygous conditions. Heterozygous overexpression of WT and M301K in neonatal rat ventricular myocytes exhibited markedly shorter action potential durations than the WT alone.
CONCLUSION: In this study, we identified a novel KCNJ2 gain-of-function mutation, M301K, associated with SQTS. Functional assays revealed no functional currents in the homozygous channels, whereas impaired inward rectification demonstrated under the heterozygous condition resulted in larger outward currents, which is a novel mechanism predisposing SQTS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155372     DOI: 10.1093/cvr/cvr329

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  30 in total

Review 1.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Stabilizer Cell Gene Therapy: A Less-Is-More Strategy to Prevent Cardiac Arrhythmias.

Authors:  Michael B Liu; Silvia G Priori; Zhilin Qu; James N Weiss
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-07-27

Review 3.  The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Authors:  Dawood Darbar
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

4.  Hydrocinnamic Acid Inhibits the Currents of WT and SQT3 Syndrome-Related Mutants of Kir2.1 Channel.

Authors:  Shuxi Ren; Chunli Pang; Yayue Huang; Chengfen Xing; Yong Zhan; Hailong An
Journal:  J Membr Biol       Date:  2017-06-28       Impact factor: 1.843

5.  Styrax blocks inward and outward current of Kir2.1 channel.

Authors:  Shuxi Ren; Chunli Pang; Junwei Li; Yayue Huang; Suhua Zhang; Yong Zhan; Hailong An
Journal:  Channels (Austin)       Date:  2016-08-12       Impact factor: 2.581

Review 6.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.

Authors:  Stanley Nattel; Dobromir Dobrev
Journal:  Nat Rev Cardiol       Date:  2016-08-04       Impact factor: 32.419

7.  Genetic Loss of IK1 Causes Adrenergic-Induced Phase 3 Early Afterdepolariz ations and Polymorphic and Bidirectional Ventricular Tachycardia.

Authors:  Louise Reilly; Francisco J Alvarado; Di Lang; Sara Abozeid; Hannah Van Ert; Cordell Spellman; Jarrett Warden; Jonathan C Makielski; Alexey V Glukhov; Lee L Eckhardt
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-08-04

8.  KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia.

Authors:  Makarand Deo; Yanfei Ruan; Sandeep V Pandit; Kushal Shah; Omer Berenfeld; Andrew Blaufox; Marina Cerrone; Sami F Noujaim; Marco Denegri; José Jalife; Silvia G Priori
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

Review 9.  Genetic mechanisms of atrial fibrillation: impact on response to treatment.

Authors:  Dawood Darbar; Dan M Roden
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

10.  [Short QT syndrome].

Authors:  C Wolpert; C Veltmann; R Schimpf; M Borggrefe; C Herrera-Siklody; U Parade; C Strotmann; N Rüb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.